Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Episode 13: Dr. Sasha Stanton (Portland, OR)
Transcript
- 0:00Her life's work is treating breast cancer patients, even
- 0:04developing a breast cancer vaccine.
- 0:06But now an organ breast oncologist finds herself on the
- 0:09other side of the treatment table, fighting the very disease
- 0:13she set out to defeat. Here's Martha Kaylee, founder
- 0:16and executive directorofearlier.org with
- 0:19today's episode of Isn't That Interesting?
- 0:23OK, welcome to this week's episode of Isn't That
- 0:27Interesting with Doctor Sasha Staton, who is a physician
- 0:32scientist with expertise in breast cancer and extensive
- 0:36training in molecular genetics and immunotherapy.
- 0:41She leads the cancer Immunoprevention laboratory at
- 0:45Early Child's Research Institute at Providence Center of
- 0:49Excellence for Immuno Oncology and Cellular Therapy.
- 0:54She is also a practicing physician at Providence in
- 0:58Portland, OR. And if I could, I would go to
- 1:01her too. And is a board certified in
- 1:04medical oncology and internal medicine.
- 1:08In 2019, she received a grant from earlier.org.
- 1:13And I'm going to have her talk about that.
- 1:15But we have some other things that might be super interesting
- 1:19to, to listen to Doctor Staten about.
- 1:22So I'm, I'm going to let you just say hi.
- 1:25And of course, we were carrying on before this happened before
- 1:29we started recording. So I'm just anxious for our, our
- 1:34listeners to hear what you have to say.
- 1:37So go. For it.
- 1:39Well, it's really nice to meet you. earlier.org was an amazing
- 1:42grant and my my research is in breast cancer prevention.
- 1:46I work on breast cancer prevention vaccines and this
- 1:50research was looking at using antibody detection for earlier
- 1:54diagnostics and improving mammography diagnostics, which
- 1:58was very ironic because earlier this year, as you can tell, I am
- 2:03don't usually wear hats. I'm not a hat person.
- 2:06I was diagnosed with breast cancer and unfortunately stage 3
- 2:09allobular breast cancer. So I have been receiving
- 2:12chemotherapy, neoadjuvant chemotherapy prior to my
- 2:15surgery, which is on New Year's Eve.
- 2:19Happy New Year. It'll be a new year.
- 2:23So my personal journey is my my mom, my grandmother and my great
- 2:29grandmother all had breast cancer.
- 2:31They were all post menopausal and so I was really considered
- 2:35routine risk. I started my screening
- 2:37mammograms at 40 because I'm a breast oncologist and and nobody
- 2:42was going to tell me I wasn't going to get my screening
- 2:43mammograms. And I had a normal screening
- 2:46mammogram in October. And then in May of this year, I
- 2:51noticed nipple retraction, which is not normal.
- 2:54And so I self detected, I guess, and told my my primary care to
- 3:01put in orders for me to get a diagnostic mammogram.
- 3:05And I think that's important for anyone, not just breast
- 3:08oncologists really. You know, your body, you are the
- 3:11expert of your body. And the number of my patients
- 3:15who say I was the one who found the mask, my husband found the
- 3:18mask, my dog found the mask. You know, really as women,
- 3:26we're, we're often taught not to pay attention to our bodies.
- 3:30We pay attention to everybody else.
- 3:32But, but really do let your doctors know when, when you're
- 3:35concerned. Because I, I, I very much hope
- 3:39we're going to have earlier detection and, and improve our
- 3:42detection sensitivities and specificities.
- 3:45But as, as we know currently with premenopausal women such as
- 3:49myself, our, our mammography does miss things and, and we
- 3:56kind of know ourselves so. Well, and you know, I think that
- 4:00what's interesting to me is when I've listened to a number of
- 4:06researchers and, and I'm so excited that our medical
- 4:12advisory committee was so interested in your work, because
- 4:19I think it's just breakthrough knowledge for, for younger
- 4:26women, particularly with dense breast tissue, the whole atypia
- 4:32cell is, has always been a concern for me.
- 4:36But it's like, well, how did it get there?
- 4:39And So what do we do with it? And and so your work with this,
- 4:45all of your process with your, your grant addresses that.
- 4:51And it, I mean, it could be, as I I perceive it, it could be you
- 4:56go in for your general. OBGYN.
- 5:01At 25 and they do a blood test. Am I?
- 5:04Crazy. No, I, I don't think that's
- 5:07crazy at all. So going going way back into
- 5:12when, when our body sees tumors, even benign tumors like atypia.
- 5:20So when, when you're, you're getting your pathology report,
- 5:24you'll get something like atypical ductal hyperplasia,
- 5:26atypical lobular hyperplasia, even fibro adenomas, all of
- 5:31these things that we find by mammogram or things that we find
- 5:34by examining ourselves that are our, our pathologists say are
- 5:38benign, they do increase our risk of developing breast
- 5:42cancer. So fibro adenomas have about a
- 5:46two to three fold increase risk, atypical like lesions like
- 5:49atypical ductal hyperplasia that goes up to about 5 fold
- 5:53increased risk over your lifetime of developing breast
- 5:56cancer. And, and so I, I often fight
- 6:00with my pathologist about this because they're like, these are
- 6:02benign. And I'm like, yes, but you know,
- 6:05they're, they're, they're beacons of we need to look at
- 6:09this more and so. Right.
- 6:13Yeah, Yeah, there, there. There's smoke, maybe there's
- 6:17fire, right. It's often what what they are.
- 6:20And So what, what I actually started with was my interest is
- 6:25in developing breast cancer prevention vaccines.
- 6:28So developing A vaccine that we could give to women regardless
- 6:32of who they are, regardless of their genetic background that
- 6:36would prevent them from developing invasive breast
- 6:39cancer. And I'd originally started at at
- 6:42the University of Washington looking at ductal carcinoma in
- 6:46site 2. So pre invasive breast lesions
- 6:49that that predict ductal cancers.
- 6:52And I've now expanded that I'm also looking at lobular
- 6:55carcinoma in site 2. Again, this is more likely
- 6:57bilateral, this is more likely multifocal and very difficult to
- 7:02detect in, in mammogram the lobular tumors because of the
- 7:06type of pathology that they are. And so I would really like to
- 7:09make a vaccine that I could go into women prior to them ever
- 7:14having breast cancer, but we're not there yet.
- 7:17And so as part of that, when when we're thinking about making
- 7:20an immune, an immune therapy, a vaccine type therapy, I wanted
- 7:25to see, does our immune system actually see these targets?
- 7:28I had found them to be overexpressed in DCIS and
- 7:31invasive breast cancer. And then does, does, does our
- 7:35immune, has our immune system seen these, these proteins
- 7:38before and done something about them, made antibodies to them,
- 7:42right. And, and my initial work that I
- 7:44brought to earlier.org was that when we looked in the blood of
- 7:48women who had atypia or fibrotinoma or DCIS or invasive
- 7:55breast cancer, we actually found an increase in these antibodies
- 7:59as compared to control women who'd come to the Puget Sound
- 8:02Blood Center to get to donate blood and as far as we knew, had
- 8:06no breast tumors. And so we brought that initial
- 8:11data, but you can't just take a single data set.
- 8:14You have to then say, OK, we saw this in one data set.
- 8:18Can we also see this in a totally independent data set?
- 8:23And so that was what I was looking at.
- 8:24And actually what we found was we validated it in a completely
- 8:28separate data set from the the Fred Hutchinson Cancer Research
- 8:32Institute up in Seattle. They had blood that they'd drawn
- 8:36from women who had abnormal mammograms but hadn't actually
- 8:41gotten a pathologic diagnosis yet.
- 8:43And then we got blood both from women who ended up having
- 8:46benign. They had a mammogram, they did a
- 8:48biopsy. It ended up being a scar or
- 8:50something, hyperplasia, fibrotinoma and DCIS and then
- 8:54each of the different breast cancer subtypes.
- 8:56So triple negative, her 2 positive and hormone receptor
- 9:00positive, her two negative. And we actually found that this
- 9:037 antibody panel that, that I had been planning to make a
- 9:08vaccine AT cell vaccine from actually really predicted that.
- 9:11And we are hopefully getting that published.
- 9:14The breast cancer kind of threw me in a loop.
- 9:16I'd hoped to get that out by October of this year.
- 9:17And I did not get there. But my plan is early next year
- 9:22to get this paper out because it's, it's I, I then in, in
- 9:26January of 2020, which was a fabulous time to move to
- 9:30Portland. I had accepted a job and got in
- 9:33a position down here and started my own independent lab.
- 9:36I had been in my mentors lab up in Washington and and then the
- 9:40world shut down because of COVID.
- 9:43But we have been moving this, this project along and really
- 9:48trying to to get it, get it out because earlier.org is a
- 9:52fantastic support really to get earlier diagnostics and earlier
- 9:59therapies and, and really try to prevent this thing so that none
- 10:02of us have to go through what either of us had to go through.
- 10:05Right. Yeah.
- 10:08So, so as we were chatting before we, we reported, it was
- 10:16like, I thought this is such a huge potential breakthrough that
- 10:22we could essentially have a blood test, really like a blood
- 10:28test. And when a 25 year old goes in
- 10:32for her first OBGYN exam, they do a blood test.
- 10:36And so you see some of these markers and OK, am I crazy with
- 10:43that or and or can you talk about how you came up with those
- 10:49particular markers? So if you would address am I
- 10:53crazy? And then.
- 10:55Go back. No, you're not, you're not.
- 10:57And we're getting to the point. So right now the test that I do
- 11:02is individual Eliza tests, which is not.
- 11:05It would be very difficult to do in a in a rapid setting for
- 11:09someone with a mammography. But there has been such an
- 11:15advance in the field since this was first funded.
- 11:19And I think that you could do, we now have the ability to do
- 11:24all of these in one single test tube type test and could do
- 11:29that, could set that up. And I have been again with the
- 11:33Hutch collecting perspective serum samples as a next level
- 11:40validation, which would be running the same 7 samples on
- 11:44samples that I don't know what they are.
- 11:46I I don't have any idea of what they are.
- 11:50And then I can then get that data and really be able to, to
- 11:56validate totally blinded, which is, would be the next set.
- 12:00And then I would need to find someone who can really Multiplex
- 12:05that I'm, I'm a little too old school for that, but well, we
- 12:10would figure it out. I, I, I have some amazing
- 12:13colleagues who do chip studies here, which is where you'd put
- 12:16all of them onto a, a chip. And I think that would be
- 12:19something we could get that we could then get into a, a early
- 12:24detection and it would really be to improve mammogram
- 12:28diagnostics. So if if you had this and an
- 12:32abnormal mammogram, you know that that the surgeons would
- 12:38want to push that to surgery even with a benign biopsy, which
- 12:42we, we say it's benign and then we take you to surgery and then
- 12:46you find invasive disease or, or you know that that that can be a
- 12:50danger with these atypical. Yeah.
- 12:54Well, and so as I see it if if you if we would have that
- 12:59particular blood test and monitoring it and you saw as you
- 13:05saw changes occurring in it even before girl women would go for
- 13:11their imaging. That.
- 13:14It would send a red flag up right it.
- 13:16Would say you. Need imaging?
- 13:19Yeah, absolutely. So other research which I have
- 13:22just been talking with the researchers about are
- 13:25amplifications of the Mris using AI that it would pick up a
- 13:32lesion like a year ahead of being able to image it.
- 13:38So. So it's just like an alert,
- 13:41right? And it would be OK, we're going
- 13:43to start here. But it makes me feel so much
- 13:46better to think that our younger women.
- 13:49Absolutely. Dense breast tissue, which I I
- 13:53knew, you know, you get the letter that says you got dense
- 13:56breast tissue. Yeah.
- 13:58OK, thanks a lot. So talk.
- 13:59To your doctor and your doctor's like.
- 14:02Yeah, OK, exactly. So, yeah, OK.
- 14:05But then this would just kind of send one of those alerts up.
- 14:09And that's what I just think is so powerful about your work.
- 14:13And I'm just so grateful to our medical Advisory Board for
- 14:20supporting you and and this work because I think this is a real
- 14:24breakthrough for us. I hope.
- 14:29So because. I very much hope that people
- 14:31don't need to do chemo, that that is the goal.
- 14:33The goal is detected early and not need to go through this.
- 14:37Well, and particularly with lobular, that is such a bear for
- 14:41diagnosing. I mean, I, I have had friends
- 14:44who have had that and it's just like, I mean, you're just
- 14:49walking in a cloud, right? It's just.
- 14:52Yeah, it's just, it's it, it the, the logular tumors lack
- 14:56that ECAD herein that keeps, keeps cells together.
- 15:00And so they, they infiltrate through the tumor through the,
- 15:04the breast. And so they, they don't make,
- 15:07they don't make calcifications, which you often, which is what
- 15:10you're really looking for in mammography.
- 15:12You're looking for these areas where there's calcifications and
- 15:15they, they, they don't tend mammography really under
- 15:20predicts lobular breast cancer. My tumor when we did the MRI was
- 15:256 centimeters. The mammogram thought it was a
- 15:28centimeter and 1/2. So it just totally
- 15:32underpredicted what it is. Now we have some new things
- 15:37coming out for imaging for that. There is contrast enhanced
- 15:43mammograms which are looking really good.
- 15:46But again, it's getting coverage for those and getting insurance
- 15:50companies to cover it and getting insurance companies to
- 15:53cover Mris. I, I was considered an, a
- 15:56regular risk patient despite having had family with breast
- 16:01cancer because they were all post menopausal and they were
- 16:03all ductal. And you know, and, and, and so I
- 16:07didn't have an MRI until it, we knew I had breast cancer.
- 16:10So, you know, I think for our younger patients who have really
- 16:15dense breasts, Mris are, are a great supplement to mammograms.
- 16:20Mammograms can detect it. I've had 25 year olds with
- 16:23mammograms detecting it. But it, it, it would be a huge
- 16:27additive to have a blood test. It would just it, it, it would
- 16:32hopefully someday provide surgeon or provide our, our
- 16:36surgical colleagues with a reason to get an MRI right.
- 16:40Or a, a, you know, a a reason to, Yeah.
- 16:45So yesterday interviewed Dr. Savannah Partridge.
- 16:52Oh, I love Savannah. Yes, she was the one I'm working
- 16:55with to get the the perspective samples.
- 16:58She's amazing, absolutely amazing.
- 17:00Well, and I thought Fusion waged imaging when you mentioned about
- 17:08the fluid translating through, Would her work be able to pick
- 17:14that up maybe quicker? Absolutely.
- 17:18So she is trying to enhance MRI so that she can detect
- 17:23differences between things like DCIS invasive cancer or LCIS
- 17:27invasive cancer, you know, to get a much better idea of what
- 17:31you're looking at. Because when you, when you get a
- 17:35mammogram and anybody out there who's had that heart dropping
- 17:39experience of getting called back, you, you don't know what
- 17:46you're looking at. They find something abnormal.
- 17:49And I come from a long line of women with fibrocystic disease.
- 17:53And my mother's just like when my mom went in and they found
- 17:57her breast cancer, which is also in 20/20/2020 was not a good
- 18:01year. They, when they did her
- 18:04mammogram, she was just like, they found something again,
- 18:09they're going to biopsy something again.
- 18:11You know, it's, it's going to be benign and you know, it was the
- 18:15time it wasn't. And, and think a lot of what
- 18:17Savannah's doing. And with that, that, that
- 18:19getting diffusion weighted imaging, you're really getting a
- 18:22lot more information. And that's they, they did
- 18:25amazing things. So, so that's where I got these
- 18:28prospective samples is they did an MRI of someone had an
- 18:32abnormal mammogram and then they drew some blood for me and I
- 18:37walked it back and forth to my lab.
- 18:38I literally walked several blocks to process and get serum.
- 18:46So how did you, I'm going to ask you one more question, How did
- 18:48you settle on those particular autoimmune situations?
- 18:53How did you come up with that seven in the panel?
- 18:57So I had a grant looking in mice and a grant looking in humans
- 19:03looking for potential candidate vaccine targets.
- 19:07So these these were why I picked those seven.
- 19:10I had originally started in my post doc I, I was a fellow in
- 19:15Doctor Noraidesis's lab and we had done a study where we had
- 19:21looked at two different mouse models, transgenic mouse models.
- 19:25So mouse mice that would go on to develop breast cancer and one
- 19:29develops her two driven breast cancer, which looks very, very
- 19:33similar to luminal B human breast cancer.
- 19:36And the other one develops triple negative.
- 19:39And we had looked to see if there were increased antibodies
- 19:44in the blood of these mice because all these mice are going
- 19:46to be very similar. So that we have we have a much
- 19:49more uniform population and we had found that there were some
- 19:53targets that were also overexpressed in women who had
- 19:56breast who who were going on to develop breast cancer and I had.
- 20:00And then the second part of the targets we picked were genes
- 20:04that were overexpressed. They weren't overexpressed in
- 20:06normal patient in normal healthy controls, but they were
- 20:10overexpressed in doctoral carcinoma site in site 2 and an
- 20:13invasive breast cancer. The genes were overexpressed.
- 20:16And so initially what I had wanted to do was I had reached
- 20:22out to the NIH sponsors, a Duke University to do a pre tumor
- 20:29Atlas. So a precancer Atlas where they
- 20:31were really looking at DCIS and trying to understand what drove
- 20:35DCIS into invasive cancer. And they had thousands of women
- 20:39that they drew their blood and they had, what they sent me was
- 20:4360 benign and 60 DCIS. And then I had samples, serum
- 20:48samples from, from the from our repository at the University of
- 20:53Washington at the Cancer Vaccine Institute.
- 20:55And then when I really dug into the benign samples, a lot of
- 20:59them were fibroidenoma, atypia. They were not normal people.
- 21:03And so I went, this is weird. So I then found more really
- 21:08healthy control women that matched the fibrinoma and I
- 21:13started looking for auto antibodies.
- 21:15I started looking at my targets I wanted to use in my vaccine
- 21:18and say, do we see antibodies to these in the blood of these
- 21:22women? And that's what what got me to
- 21:24put in this this grant and select those seven.
- 21:27Those were the most highly overexpressed.
- 21:29They were targets that were very, we knew they were
- 21:33important in breast cancer and we found them to be important
- 21:37for survival of the breast tumor across all of the different
- 21:40breast cancer subtypes. So that's really what made me
- 21:43say these are really good targets to select to really try
- 21:47to catch that population. I think that help.
- 21:51Yeah, it's, I think that's just amazing how it came about.
- 21:56To tell you the truth. It's just like it was kind of a
- 21:59wink for us. Yeah, it was AI did not expect
- 22:03it was going to show anything. I was like, we may not even see
- 22:05antibodies, let's try it. My boss thought I was crazy and
- 22:11I looked and I'm like, well, we actually have a signal here.
- 22:17Let's let's validate that signal.
- 22:20That's what science is. That's that's we look in One
- 22:23Direction and then we. And that's the fun of it, right?
- 22:27I mean, it's like always a surprise.
- 22:29And I have always enjoyed science.
- 22:33And in my first life, I'm a pharmacist, so.
- 22:36Oh my goodness, yes. One of the things that I've just
- 22:39thought was probably I should have done something more
- 22:43biological, but I really appreciate your work and your
- 22:49thinking and pulling all those things together.
- 22:51It's just amazing. And so congratulations to you
- 22:56and I look forward to being able to share this with one of our
- 23:01episodes and it should be coming up pretty soon.
- 23:03So. Well, that's so.
- 23:05Exciting for. Visiting with us and we will
- 23:08well. And you have a fantastic grant.
- 23:10It's really an amazing grant funding.
- 23:12It's, it's, it's to get that next step so that we can try to
- 23:16really get the bigger grants or the retrospective data or the
- 23:21prospective data. So.
- 23:22Well, and, and it, I mean, I appreciate the proof of concept
- 23:26because you just can't, we're not going to solve this if we
- 23:31just keep driving down the same Rd.
- 23:34You know, it's like we've got to, we've got to open our minds
- 23:38to bigger things, which you have done.
- 23:40And I'm just so appreciative and I'm can't wait to see it.
- 23:43Could you get it ready by next week?
- 23:45I mean, I don't want to hurry you or anything.
- 23:49It would be great. So.
- 23:52I don't think so. I can try just.
- 23:55Keep crying, all right? And good luck to you.
- 23:57I'm finishing up with your treatment.
- 23:59Yeah, no, it's, it's, it's getting close.
- 24:02Next week is my last week. So very much looking forward to.
- 24:06That oh, you won't even know what to do without your hats
- 24:08then, will you? Oh no, my hair will take time to
- 24:11come back. I know that.
- 24:12I, my patients are amazing. They're, they're, they, they
- 24:16have the, the biggest sense of humor and they're just like,
- 24:20well, welcome to our side. I'm sure.
- 24:24Well, thank you so much, Doctor Stanton.
- 24:27Absolutely. And good luck on everything.
- 24:30OK. Oh.
- 24:31Thank you. Thank you.
- 24:32And I will let you know when when we get it ready for
- 24:34publication. We're working on it.
- 24:36We really are. Thank.
- 24:37You OK? Bye bye.
- 24:40This episode of Isn't That Interesting was made possible
- 24:43thanks to volunteers and donors just like you.
- 24:46It was hosted by Martha Kaley, founderofearlier.org and edited
- 24:50by Liam Mcburney. I'm Valerie Amsterdam, reminding
- 24:54you that for the last 30 years, this North Carolina based
- 24:57organization has helped fund groundbreaking research all over
- 25:01the world, from molecular imaging to a sensitive blood
- 25:04test for breast cancer. Plain and simple, earlier
- 25:07detection saves lives. And you can help host a
- 25:11fundraising event. Make a donation for Volunteer
- 25:13Your Time. You can find us not only on the
- 25:16web but on Facebook and Instagram too.
- 25:19Let's change the picture of breast cancer together.